Intercept Pharmaceuticals
ICPT
$19.00
Share price
0.00%
Change (1 day)
-7.90%
Change (1 year)
Categories
EPS for Intercept Pharmaceuticals (ICPT)
EPS in 2023 (TTM): $6.39
According to Intercept Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is $6.39. In 2022 the company made an earnings per share (EPS) of $6.47 an increase over its 2021 EPS that were of -$2.89.
EPS history for Intercept Pharmaceuticals from 2012 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $6.39 | -1.24% |
| 2022 | $6.47 | -323.88% |
| 2021 | -$2.89 | -65.47% |
| 2020 | -$8.37 | -23.14% |
| 2019 | -$10.89 | -0.55% |
| 2018 | -$10.95 | -23.91% |
| 2017 | -$14.39 | -14.04% |
| 2016 | -$16.74 | 76.4% |
| 2015 | -$9.49 | -33.78% |
| 2014 | -$14.33 | 290.46% |
| 2013 | -$3.67 | -29.37% |
| 2012 | -$5.20 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | $5.43 | -15.03% | 🇺🇸 USA |
 Gilead Sciences GILD | $4.39 | -31.30% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $3.97 | -37.87% | 🇺🇸 USA |
 MediciNova MNOV | -$0.25 | -103.91% | 🇺🇸 USA |